Tomas Ohlsson

4.9k total citations
91 papers, 2.7k citations indexed

About

Tomas Ohlsson is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Tomas Ohlsson has authored 91 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Radiology, Nuclear Medicine and Imaging, 18 papers in Pulmonary and Respiratory Medicine and 15 papers in Oncology. Recurrent topics in Tomas Ohlsson's work include Radiopharmaceutical Chemistry and Applications (29 papers), Medical Imaging Techniques and Applications (22 papers) and Alzheimer's disease research and treatments (14 papers). Tomas Ohlsson is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (29 papers), Medical Imaging Techniques and Applications (22 papers) and Alzheimer's disease research and treatments (14 papers). Tomas Ohlsson collaborates with scholars based in Sweden, Denmark and United States. Tomas Ohlsson's co-authors include Ruben Smith, Oskar Hansson, Sven‐Erik Strand, Olof Strandberg, Michael Schöll, Jan Tennvall, Jonas Jögi, Sebastian Palmqvist, Niklas Mattsson and Rik Ossenkoppele and has published in prestigious journals such as Journal of Clinical Oncology, Brain and Neurology.

In The Last Decade

Tomas Ohlsson

89 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tomas Ohlsson Sweden	26	1.0k	963	753	378	361	91	2.7k
Stefan Förster Germany	34	1.2k 1.2×	629 0.7×	721 1.0×	305 0.8×	278 0.8×	121	3.4k
Jacques Darcourt France	27	1.1k 1.1×	487 0.5×	758 1.0×	821 2.2×	287 0.8×	112	3.0k
Maqsood Yaqub Netherlands	35	2.0k 2.0×	1.0k 1.1×	1.0k 1.3×	274 0.7×	590 1.6×	186	4.0k
Bradley J. Kemp United States	23	779 0.8×	1.4k 1.5×	1.3k 1.8×	187 0.5×	177 0.5×	39	2.8k
Yihui Guan China	27	516 0.5×	589 0.6×	280 0.4×	660 1.7×	188 0.5×	152	2.2k
Agostino Chiaravalloti Italy	26	568 0.6×	346 0.4×	292 0.4×	262 0.7×	400 1.1×	131	2.0k
Hyemin Jang South Korea	26	320 0.3×	783 0.8×	889 1.2×	302 0.8×	185 0.5×	174	2.3k
H. Radner Austria	26	647 0.6×	575 0.6×	462 0.6×	526 1.4×	553 1.5×	65	3.6k
Gianmario Sambuceti Italy	44	2.7k 2.6×	665 0.7×	440 0.6×	549 1.5×	710 2.0×	249	6.1k
Nelleke Tolboom Netherlands	22	631 0.6×	749 0.8×	728 1.0×	191 0.5×	84 0.2×	69	1.9k

Countries citing papers authored by Tomas Ohlsson

Since Specialization

Citations

This map shows the geographic impact of Tomas Ohlsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Ohlsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Ohlsson more than expected).

Fields of papers citing papers by Tomas Ohlsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomas Ohlsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Ohlsson. The network helps show where Tomas Ohlsson may publish in the future.

Co-authorship network of co-authors of Tomas Ohlsson

This figure shows the co-authorship network connecting the top 25 collaborators of Tomas Ohlsson. A scholar is included among the top collaborators of Tomas Ohlsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas Ohlsson. Tomas Ohlsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, Ruben, Douglas Hägerström, Gregory Klein, et al.. (2023). Clinical Utility of Tau Positron Emission Tomography in the Diagnostic Workup of Patients With Cognitive Symptoms. JAMA Neurology. 80(7). 749–749. 18 indexed citations

Bratteby, Klas, Vladimir Shalgunov, Umberto Maria Battisti, et al.. (2021). Insights into Elution of Anion Exchange Cartridges: Opening the Path toward Aliphatic ¹⁸ F-Radiolabeling of Base-Sensitive Tracers. ACS Pharmacology & Translational Science. 4(5). 1556–1566. 26 indexed citations

Cleton, Adriaan, et al.. (2020). Feasibility of Thorium-227/Radium-223 Gamma-Camera Imaging During Radionuclide Therapy. Cancer Biotherapy and Radiopharmaceuticals. 35(7). 540–548. 13 indexed citations

Shalgunov, Vladimir, Balázs Volk, Simone Larsen Bærentzen, et al.. (2019). Development and Evaluation of Two Potential 5-HT₇ Receptor PET Tracers: [¹⁸F]ENL09 and [¹⁸F]ENL10. ACS Chemical Neuroscience. 10(9). 3961–3968. 8 indexed citations

Almquist, Helén, Martin Almquist, Cécilia Hindorf, et al.. (2019). A Prospective Observational Study to Evaluate the Effects of Long-Acting Somatostatin Analogs on⁶⁸Ga-DOTATATE Uptake in Patients with Neuroendocrine Tumors. Journal of Nuclear Medicine. 60(12). 1717–1723. 23 indexed citations

Erlandsson, Maria, et al.. (2019). Towards selective CNS PET imaging of the 5-HT7 receptor system: Past, present and future. Neuropharmacology. 172. 107830–107830. 16 indexed citations

Shalgunov, Vladimir, François Crestey, Ramesh Neelamegam, et al.. (2019). Radiosynthesis and preclinical evaluation of [¹¹C]Cimbi‐701 – Towards the imaging of cerebral 5‐HT₇ receptors. Journal of Labelled Compounds and Radiopharmaceuticals. 63(2). 46–55. 5 indexed citations

Shalgunov, Vladimir, Simone Larsen Bærentzen, Maria Erlandsson, et al.. (2019). Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of [¹⁸F]ENL30: A Potential PET Radiotracer for the 5-HT₇ Receptor. ACS Omega. 4(4). 7344–7353. 11 indexed citations

Hansen, Hanne D., Sascha Jung, Hartmut Lüddens, et al.. (2019). Synthesis and Pharmacological Evaluation of [¹¹C]4-Methoxy-N-[2-(thiophen-2-yl)imidazo[1,2-a]pyridin-3-yl]benzamide as a Brain Penetrant PET Ligand Selective for the δ-Subunit-Containing γ-Aminobutyric Acid Type A Receptors. ACS Omega. 4(5). 8846–8851. 7 indexed citations

10.

Jönsson, Lena, et al.. (2018). Quantitative analysis of phantom studies of 111In and 68Ga imaging of neuroendocrine tumours. EJNMMI Physics. 5(1). 5–5. 11 indexed citations

11.

Smith, Ruben, Andreas Puschmann, Michael Schöll, et al.. (2016). ¹⁸ F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers. Brain. 139(9). 2372–2379. 130 indexed citations

12.

Bäck, Tom, Tomas Ohlsson, Holger Jensen, et al.. (2014). Sequential Radioimmunotherapy with ¹⁷⁷ Lu- and ²¹¹ At-Labeled Monoclonal Antibody BR96 in a Syngeneic Rat Colon Carcinoma Model. Cancer Biotherapy and Radiopharmaceuticals. 29(6). 238–246. 7 indexed citations

13.

Ljungberg, Otto, Anders Örbom, Sven‐Erik Strand, et al.. (2014). Change in Cell Death Markers During ¹⁷⁷ Lu-mAb Radioimmunotherapy-Induced Rejection of Syngeneic Rat Colon Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 29(4). 143–152. 3 indexed citations

14.

Ohlsson, Tomas, et al.. (2012). Treatment with Unlabeled mAb BR96 After Radioimmunotherapy with ¹⁷⁷ Lu-DOTA-BR96 in a Syngeneic Rat Colon Carcinoma Model. Cancer Biotherapy and Radiopharmaceuticals. 27(3). 175–182. 7 indexed citations

15.

Ohlsson, Tomas, et al.. (2012). Repeated Radioimmunotherapy with ¹⁷⁷ Lu-DOTA-BR96 in a Syngeneic Rat Colon Carcinoma Model. Cancer Biotherapy and Radiopharmaceuticals. 27(2). 134–140. 10 indexed citations

16.

Mårtensson, Linda, Rune Nilsson, Tomas Ohlsson, et al.. (2010). High‐dose radioimmunotherapy combined with extracorporeal depletion in a syngeneic rat tumor model. Cancer. 116(S4). 1043–1052. 13 indexed citations

17.

Lindén, Ola, Jan Kurkus, Michael Garkavij, et al.. (2005). A Novel Platform for Radioimmunotherapy: Extracorporeal Depletion of Biotinylated and ⁹⁰ Y-Labeled Rituximab in Patients with Refractory B-Cell Lymphoma. Cancer Biotherapy and Radiopharmaceuticals. 20(4). 457–466. 28 indexed citations

18.

Wang, Zhong-Min, et al.. (2003). Biotinylation, Pharmacokinetics, and Extracorporeal Adsorption of Humanized MAb ¹¹¹ In-MN14 Using an Avidin-Affinity Column in Rats. Cancer Biotherapy and Radiopharmaceuticals. 18(3). 365–375. 4 indexed citations

19.

Brun, Eva, Elisabeth Kjellén, Jan Tennvall, et al.. (2002). FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma. Head & Neck. 24(2). 127–135. 210 indexed citations

20.

Lindén, Ola, Eva Cavallin‐Ståhl, Tomas Ohlsson, et al.. (2001). Durable response to 90-yttrium-Epratuzumab (hLL2) in B-cell lymphoma failing chemotherapy by using dose-fractionation schedule. Lund University Publications (Lund University). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact